Use of salmeterol with and without concurrent use of inhaled corticosteroids and the risk of asthma-related hospitalization among patients with asthma.

@article{Wang2008UseOS,
  title={Use of salmeterol with and without concurrent use of inhaled corticosteroids and the risk of asthma-related hospitalization among patients with asthma.},
  author={Meng-Ting Wang and Grant H Skrepnek and Edward Armstrong and Duane L. Sherrill and Robin B. Harris and Cheng-Liang Tsai and Daniel C. Malone},
  journal={Current medical research and opinion},
  year={2008},
  volume={24 3},
  pages={
          859-67
        }
}
RATIONALE Studies evaluating the safety of salmeterol are inconclusive, which might be the result from not taking into account the impact of concomitant inhaled corticosteroids (ICS). OBJECTIVE To study whether salmeterol use with and without concomitant ICS, respectively, was associated with an increased risk of asthma-related hospitalizations among patients with asthma. METHODS A case-control study nested within a cohort of patients with asthma, identified in the year 2000, over a 2-year… CONTINUE READING